{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:57:25Z","timestamp":1772585845206,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Major Scientific Research Projects of National Clinical Key Specialties in 2023","award":["Z2023087"],"award-info":[{"award-number":["Z2023087"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05536-y","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:45:26Z","timestamp":1770043526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety profile of ticagrelor: an analysis based on literature and database review"],"prefix":"10.1186","volume":"26","author":[{"given":"Renzhu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"10233","key":"5536_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S0140-6736(20)30325-1","volume":"395","author":"M Gimbel","year":"2020","unstructured":"Gimbel M, Qaderdan K, Willemsen L, Hermanides R, Bergmeijer T, de Vrey E, Heestermans T, Tjon JGM, Waalewijn R, Hofma S, et al. Clopidogrel versus Ticagrelor or Prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. Lancet. 2020;395(10233):1374\u201381.","journal-title":"Lancet"},{"issue":"6","key":"5536_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nrcardio.2016.61","volume":"13","author":"K Huynh","year":"2016","unstructured":"Huynh K. Antiplatelet therapy: Ticagrelor reduces cardiac events in patients with PAD or diabetes. NAT REV CARDIOL. 2016;13(6):310\u20131.","journal-title":"NAT REV CARDIOL"},{"issue":"21","key":"5536_CR3","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1111\/bph.16500","volume":"181","author":"K Pyrshev","year":"2024","unstructured":"Pyrshev K, Allemand F, Rabani V, Yesylevskyy S, Davani S, Ramseyer C, Lagoutte-Renosi J. Ticagrelor increases its own potency at the P2Y(12) receptor by directly changing the plasma membrane lipid order in platelets. BRIT J PHARMACOL. 2024;181(21):4369\u201380.","journal-title":"BRIT J PHARMACOL"},{"issue":"13","key":"5536_CR4","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jcin.2017.04.027","volume":"10","author":"F Rollini","year":"2017","unstructured":"Rollini F, Franchi F, Thano E, Faz G, Park Y, Kureti M, Cho JR, Been L, Bass TA, Angiolillo DJ. In vitro pharmacodynamic effects of Cangrelor on platelet P2Y(12) Receptor-Mediated signaling in Ticagrelor-Treated patients. JACC-CARDIOVASC INTE. 2017;10(13):1374\u20135.","journal-title":"JACC-CARDIOVASC INTE"},{"key":"5536_CR5","doi-asserted-by":"publisher","first-page":"667234","DOI":"10.3389\/fneur.2021.667234","volume":"12","author":"A Alhazzani","year":"2021","unstructured":"Alhazzani A, Venkatachalapathy P, Padhilahouse S, Sellappan M, Munisamy M, Sekaran M, Kumar A. Biomarkers for antiplatelet therapies in acute ischemic stroke: A clinical review. FRONT NEUROL. 2021;12:667234.","journal-title":"FRONT NEUROL"},{"key":"5536_CR6","doi-asserted-by":"crossref","unstructured":"Sidiropoulou S, Gatsiou A, Hansson KM, Tsouka AN, Stellos K, Tselepis AD. Ticagrelor Induces Angiogenesis in Progenitor and Mature Endothelial Cells In Vitro: Investigation of the Possible Role of Adenosine. Int J Mol Sci. 2024;25(24):13343.","DOI":"10.3390\/ijms252413343"},{"issue":"3","key":"5536_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.cjco.2024.11.022","volume":"7","author":"VH Vu","year":"2025","unstructured":"Vu VH, Bui DT, Nguyen VX, Pham Q, Duong BT, Truong BQ. Electrical storm potentially associated with ticagrelor: A case report and literature review. CJC Open. 2025;7(3):270\u20134.","journal-title":"CJC Open"},{"key":"5536_CR8","first-page":"200311","volume":"22","author":"A Farzaei","year":"2024","unstructured":"Farzaei A, Mehrabi NE, Jenab Y, Amirzadegan A, Khodayari JA, Eisvand M, Hajzeinolabedini F, Bozorgi A. An interesting case series of Ticagrelor induced long QTc. Int J Cardiol Cardiovasc Risk Prev. 2024;22:200311.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"2","key":"5536_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.18087\/cardio.2024.2.n2123","volume":"64","author":"B Murat","year":"2024","unstructured":"Murat B, Murat S, Kivanc E. Ticagrelor Induced Cheyne-Stokes Respiration and Asystolic Ventricular Standstill: A Case Report. KARDIOLOGIYA. 2024;64(2):80\u20134.","journal-title":"KARDIOLOGIYA"},{"issue":"7","key":"5536_CR10","first-page":"e41821","volume":"15","author":"NT Pavlatos","year":"2023","unstructured":"Pavlatos NT, Shah A, Khan M, Jaiswal V, Mattumpuram J. A case of Ticagrelor-Induced sinus pause. CUREUS J MED Sci. 2023;15(7):e41821.","journal-title":"CUREUS J MED Sci"},{"key":"5536_CR11","doi-asserted-by":"crossref","unstructured":"Cesarini D, Muraca I, Berteotti M, Gori AM, Sorrentino A, Bertelli A, Marcucci R, Valenti R. Pathophysiological and molecular basis of the side effects of ticagrelor: lessons from a case report. Int J Mol Sci. 2023;24(13):10844.","DOI":"10.3390\/ijms241310844"},{"key":"5536_CR12","doi-asserted-by":"crossref","unstructured":"Bu SH, Kim SH. Ticagrelor-Induced Torsades de Pointes following Myocardial Infarction. Case Rep Cardiol. 2022;2022:4505964.","DOI":"10.1155\/2022\/4505964"},{"issue":"12","key":"5536_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.14740\/jmc3815","volume":"12","author":"A Al-Bayati","year":"2021","unstructured":"Al-Bayati A, Wiseman K, Udongwo N, Ajam F, Hansalia R, Apolito R. Heart block caused by Ticagrelor use in a patient who underwent adenosine diastolic fractional reserve assessment: A case report. J Med Cases. 2021;12(12):499\u2013502.","journal-title":"J Med Cases"},{"issue":"10","key":"5536_CR14","doi-asserted-by":"publisher","first-page":"e5017","DOI":"10.1002\/ccr3.5017","volume":"9","author":"A Rahhal","year":"2021","unstructured":"Rahhal A, Aljundi A, Ibrahim MS, Arif MA, Arabi AR. Prolonged ventricular pause associated with Ticagrelor use: A case report. CLIN CASE REP. 2021;9(10):e5017.","journal-title":"CLIN CASE REP"},{"issue":"5","key":"5536_CR15","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1097\/MJT.0000000000001385","volume":"29","author":"S Zulfiqar","year":"2022","unstructured":"Zulfiqar S, Saleem M, Jilani MH, Siddiqui F, Arif I, Waqar F. Sinus arrest associated with Ticagrelor therapy: A case report and review of literature. AM J THER. 2022;29(5):e585\u20138.","journal-title":"AM J THER"},{"issue":"1","key":"5536_CR16","first-page":"e12874","volume":"13","author":"V Kotaru","year":"2021","unstructured":"Kotaru V, Kalavakunta JK. Ticagrelor-Induced Syncope\/Bradyarrhythmia. CUREUS J MED Sci. 2021;13(1):e12874.","journal-title":"CUREUS J MED Sci"},{"issue":"9","key":"5536_CR17","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0218492320981483","volume":"29","author":"P Aranganathan","year":"2021","unstructured":"Aranganathan P, Wilson B, Rangan A, Boopathi A, Balasundaram R. A rare case of late-onset ticagrelor-induced sinus arrest. ASIAN CARD THORAC AN. 2021;29(9):946\u20139.","journal-title":"ASIAN CARD THORAC AN"},{"issue":"5","key":"5536_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa156","volume":"4","author":"M Arioti","year":"2020","unstructured":"Arioti M, Sirianni G, Laudisa ML, De Cesare NB. A rare but serious complication of Ticagrelor therapy: a case report. EUR HEART J-CASE REP. 2020;4(5):1\u20135.","journal-title":"EUR HEART J-CASE REP"},{"key":"5536_CR19","doi-asserted-by":"publisher","unstructured":"Ray A, Najmi A, Khandelwal G, Sadasivam B. Ticagrelor-Induced Prolongation of the QTc Interval. Case Rep Cardiol. 2019;2019:5984847. https:\/\/doi.org\/10.1155\/2019\/5984847.","DOI":"10.1155\/2019\/5984847"},{"issue":"1","key":"5536_CR20","first-page":"y156","volume":"3","author":"A Low","year":"2019","unstructured":"Low A, Leong K, Sharma A, Oqueli E. Ticagrelor-associated ventricular pauses: a case report and literature review. EUR HEART J-CASE REP. 2019;3(1):y156.","journal-title":"EUR HEART J-CASE REP"},{"issue":"11","key":"5536_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.hrcr.2018.07.017","volume":"4","author":"V Waldmann","year":"2018","unstructured":"Waldmann V, Laredo M, Nigam A, Khairy P. Cyclical sinus bradycardia and atrioventricular block induced by Ticagrelor. HeartRhythm Case Rep. 2018;4(11):527\u20139.","journal-title":"HeartRhythm Case Rep"},{"key":"5536_CR22","doi-asserted-by":"publisher","unstructured":"Li X, Xue Y, Wu H. A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration. Case Rep Vasc Med. 2018;2018:9385017. https:\/\/doi.org\/10.1155\/2018\/9385017.","DOI":"10.1155\/2018\/9385017"},{"issue":"8","key":"5536_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.7326\/L17-0550","volume":"168","author":"S Rosset","year":"2018","unstructured":"Rosset S, Muller O, Pruvot E, Pascale P. Prolonged Asystole after a loading dose of Ticagrelor. ANN INTERN MED. 2018;168(8):602\u20133.","journal-title":"ANN INTERN MED"},{"issue":"3","key":"5536_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.14740\/cr556w","volume":"8","author":"M Yurtdas","year":"2017","unstructured":"Yurtdas M, Ozdemir M. Ticagrelor-Associated conduction disorder: A case report and review of the literature. CARDIOL RES. 2017;8(3):123\u20137.","journal-title":"CARDIOL RES"},{"issue":"5","key":"5536_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/FJC.0000000000000518","volume":"70","author":"L Conte","year":"2017","unstructured":"Conte L, Pugliese NR, Giannoni A. Reversal of Ticagrelor-Induced arrhythmias and Cheyne-Stokes respiration with aminophylline infusion. J CARDIOVASC PHARM. 2017;70(5):290\u20132.","journal-title":"J CARDIOVASC PHARM"},{"issue":"5","key":"5536_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.12998\/wjcc.v5.i5.178","volume":"5","author":"E De Maria","year":"2017","unstructured":"De Maria E, Borghi A, Modonesi L, Cappelli S. Ticagrelor therapy and atrioventricular block: do we need to worry? WORLD J CLIN CASES. 2017;5(5):178\u201382.","journal-title":"WORLD J CLIN CASES"},{"key":"5536_CR27","doi-asserted-by":"publisher","unstructured":"Sharma M, Mascarenhas DA. Ticagrelor Associated Heart Block: The Need for Close and Continued Monitoring. Case Rep Cardiol. 2017;2017:5074891. https:\/\/doi.org\/10.1155\/2017\/5074891.","DOI":"10.1155\/2017\/5074891"},{"issue":"1","key":"5536_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/0897190016680978","volume":"31","author":"SA Minner","year":"2018","unstructured":"Minner SA, Simone P, Chung BB, Shah AP. Successful reversal of bradycardia and dyspnea with aminophylline after Ticagrelor load. J PHARM PRACT. 2018;31(1):112\u20134.","journal-title":"J PHARM PRACT"},{"key":"5536_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijcard.2016.03.143","volume":"214","author":"NC Baker","year":"2016","unstructured":"Baker NC, Nadour W, Friehling M. Clinically significant Ticagrelor induced conduction abnormalities following percutaneous coronary intervention. INT J CARDIOL. 2016;214:21\u20132.","journal-title":"INT J CARDIOL"},{"key":"5536_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ijcard.2016.03.091","volume":"212","author":"N Zhang","year":"2016","unstructured":"Zhang N, Chen KY, Zhao J, Xu G, Li G, Liu T. Another side effect of ticagrelor: atrial fibrillation. INT J CARDIOL. 2016;212:242\u20134.","journal-title":"INT J CARDIOL"},{"key":"5536_CR31","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ijcard.2015.11.042","volume":"203","author":"C Ozturk","year":"2016","unstructured":"Ozturk C, Unlu M, Yildirim AO, Erdogan S, Demir M, Balta S, Demirkol S, Celik T, Iyisoy A. The progressed atrioventricular block associated with Ticagrelor therapy May not require permanent pacemaker after acute coronary syndrome; it May be reversible. INT J CARDIOL. 2016;203:822\u20134.","journal-title":"INT J CARDIOL"},{"key":"5536_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijcard.2015.04.198","volume":"191","author":"M Nicol","year":"2015","unstructured":"Nicol M, Deblaise J, Choussat R, Dubourg O, Mansencal N. Side effects of ticagrelor: sinus node dysfunction with ventricular pause. INT J CARDIOL. 2015;191:56\u20137.","journal-title":"INT J CARDIOL"},{"key":"5536_CR33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijcard.2014.12.162","volume":"182","author":"A Goldberg","year":"2015","unstructured":"Goldberg A, Rosenfeld I, Nordkin I, Halabi M. Life-threatening complete atrioventricular block associated with Ticagrelor therapy. INT J CARDIOL. 2015;182:379\u201380.","journal-title":"INT J CARDIOL"},{"issue":"6","key":"5536_CR34","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s43440-021-00309-0","volume":"73","author":"MA Akkaif","year":"2021","unstructured":"Akkaif MA, Ng ML, Sk AKM, Daud N, Sha\u2019Aban A, Ibrahim B. A review of the effects of Ticagrelor on adenosine concentration and its clinical significance. PHARMACOL REP. 2021;73(6):1551\u201364.","journal-title":"PHARMACOL REP"},{"issue":"2","key":"5536_CR35","doi-asserted-by":"publisher","first-page":"102704","DOI":"10.1016\/j.rpth.2025.102704","volume":"9","author":"D Mutschlechner","year":"2025","unstructured":"Mutschlechner D, Tscharre M, Wadowski PP, Lee S, Pultar J, Weikert C, Panzer S, Gremmel T. Elderly patients are hyperresponsive to potent P2Y12 inhibitors. RES PRACT THROMB HAE. 2025;9(2):102704.","journal-title":"RES PRACT THROMB HAE"},{"key":"5536_CR36","doi-asserted-by":"crossref","unstructured":"Mansoor H, Poudel R, Hong H, Li S, Thomas K, Sigal S, Tamis-Holland J, Goyal A, Elgendy IY. Sex differences in high-potency P2Y12 inhibitors prescription among patients with acute myocardial infarction. Cardiovasc Revascula. 2025;S1553-8389(25):00390-2.","DOI":"10.1016\/j.carrev.2025.07.007"},{"key":"5536_CR37","doi-asserted-by":"publisher","first-page":"937261","DOI":"10.3389\/fcvm.2022.937261","volume":"9","author":"W Peng","year":"2022","unstructured":"Peng W, Zhang Y, Lin Y. Low-dose and standard-dose Ticagrelor compared with clopidogrel in patients with acute coronary syndromes: A cohort study from China. FRONT CARDIOVASC MED. 2022;9:937261.","journal-title":"FRONT CARDIOVASC MED"},{"issue":"11","key":"5536_CR38","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1096\/fj.201600616R","volume":"30","author":"A Mediero","year":"2016","unstructured":"Mediero A, Wilder T, Reddy VS, Cheng Q, Tovar N, Coelho PG, Witek L, Whatling C, Cronstein BN. Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism. FASEB J. 2016;30(11):3887\u2013900.","journal-title":"FASEB J"},{"issue":"1","key":"5536_CR39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13075-016-1089-8","volume":"18","author":"A Bortoluzzi","year":"2016","unstructured":"Bortoluzzi A, Vincenzi F, Govoni M, Padovan M, Ravani A, Borea PA, Varani K. A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus. ARTHRITIS RES THER. 2016;18(1):192.","journal-title":"ARTHRITIS RES THER"},{"key":"5536_CR40","doi-asserted-by":"publisher","first-page":"105089","DOI":"10.1016\/j.phrs.2020.105089","volume":"160","author":"I Pujade","year":"2020","unstructured":"Pujade I, Perino J, Mathieu C, Arnaud M, Raschi E, Gatti M, Bezin J, Salvo F. Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis. PHARMACOL RES. 2020;160:105089.","journal-title":"PHARMACOL RES"},{"issue":"6","key":"5536_CR41","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s00392-025-02629-0","volume":"114","author":"C Salbach","year":"2025","unstructured":"Salbach C, Yildirim M, Gulba R, Milles BR, Biener M, Mueller-Hennessen M, Hund H, Frey N, Giannitsis E. Dual antiplatelet pre-treatment with aspirin and Ticagrelor in ACS patients undergoing unplanned aortocoronary bypass surgery. CLIN RES CARDIOL. 2025;114(6):772\u201382.","journal-title":"CLIN RES CARDIOL"},{"issue":"10","key":"5536_CR42","first-page":"e46455","volume":"15","author":"S Maqbool","year":"2023","unstructured":"Maqbool S, Ali MS, Rehman A, Ur RM, Iqbal J, Razzaq A, Kamal A, Shivamadhu SS, Afzal M, Fazal F, et al. Efficacy and safety profile of Ticagrelor versus clopidogrel in percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS): A systematic review and Meta-Analysis. CUREUS J MED Sci. 2023;15(10):e46455.","journal-title":"CUREUS J MED Sci"},{"issue":"16","key":"5536_CR43","doi-asserted-by":"publisher","first-page":"e30879","DOI":"10.1161\/JAHA.123.030879","volume":"12","author":"M Yildirim","year":"2023","unstructured":"Yildirim M, Mueller-Hennessen M, Milles BR, Biener M, Hund H, Frey N, Giannitsis E, Salbach C. Real-World evidence on disparities on the initiation of Ticagrelor versus Prasugrel in patients with acute coronary syndrome. J AM HEART ASSOC. 2023;12(16):e30879.","journal-title":"J AM HEART ASSOC"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05536-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05536-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05536-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:06:29Z","timestamp":1772582789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05536-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5536"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05536-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}